Publications and Presentations
“A Model to Evaluate the Impact of Hospital-Based Interventions Targeting False-positive Blood Cultures on Economic and Clinical Outcomes“ – Journal of Hospital Infection, March 2019.
“Cost-effectiveness and projected survival of self-expanding transcatheter versus surgical aortic valve replacement for high-risk patients in a European setting: a Dutch analysis based on the CoreValve high-risk trial.” – Structural Heart, Sept. 2017.
“Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer – Thoracic Oncology, May 2017.
“Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States” – Neuromodulation, August 2016.
“Cost-Effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension” - Journal of the American College of Cardiology, Oct. 2012.
Pietzsch JB. Richter A-K, Randerath W, Steffen A, Liu S, Geisler BP, Wasem J, Biermann-Stallwitz J. “Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting,” Respiration.
Geisler BP, Jilg N, Patton RG, Pietzsch JB. “A Model to Evaluate the Impact of Hospital-Based Interventions Targeting False-positive Blood Cultures on Economic and Clinical Outcomes,“ Journal of Hospital Infection.
Peiffer V, Yock CA, Yock PG, Pietzsch JB. “Value-Based Care: A Review of Key Challenges and Opportunities Relevant to Medical Technology Innovators,” Journal of Medical Devices.
Schaefer A, Lubos E, Pietzsch JB, Pietzsch M, Weber S, Blankenberg S, Reichenspurner H, Schäfer U, Conradi L. “Insights from eight years of adoption experience of transcatheter mitral valve repair in Germany: observed utilisation patterns and impact on overall mitral valve procedure volumes,” EuroIntervention. 2018;14(9):e981–e987; doi: 10.4244/EIJ-D-18-00403.
Pietzsch JB, Busca R, Rott C, Geisler BP, Weber SA, Slebos DJ, Deslee G, Herth FJF. “Adoption Patterns of Bronchoscopic Lung Volume Reduction Procedures in Germany and Predicted Procedure Volumes for Other European Countries,” Respiration. 2018; Epub ahead of print, 17 August 2018; doi: 10.1159/000491677.
Perl L, Peiffer V, Fuhrer A, D’Ascenzo F, Pietzsch JB. “Sex differences in discharge destination following acute myocardial infarction,” Coronary Artery Disease: September 2018 – Volume 29 – Issue 6 – p 502–510.doi: 10.1097/MCA.0000000000000643
Pietzsch JB, Weber SA, Lund N, Gaul C. “Changes in Medication Cost Observed in Chronic Cluster Headache Patients Treated with Sphenopalatine Ganglion (SPG) Stimulation: Analysis Based on 1-Year Data from the Pathway R-1 Registry,” Cephalalgia. 2018;38(8)1455–1462; doi: 10.1177/0333102418784689.
Faucett SC, Geisler BP, Chahla J, Krych AJ, Kurzweil PR, Garner AM, Liu S, LaPrade RF, Pietzsch JB. “Meniscus Root Repair vs Meniscectomy or Nonoperative Management to Prevent Knee Osteoarthritis after Medial Meniscus Root Tears: Clinical and Economic Effectiveness,” Am J Sports Med. 2018; Epub ahead of print, 1 March 2018; doi: 10.1177/0363546518755754.
Geisler BP, Huygens SA, Reardon MJ, Van Mieghem N, Kappetein AP, Osnabrugge RLJ, Pietzsch JB. Cost-effectiveness and projected survival of self-expanding transcatheter versus surgical aortic valve replacement for high-risk patients in a European setting: a Dutch analysis based on the CoreValve high-risk trial. Structural Heart. Online ahead of print Sept. 9, 2017; doi: 10.1080/24748706.2017.1381357.
Pietzsch JB, Geisler BP, Ikeno F. Cost-effectiveness of orbital atherectomy compared to rotational atherectomy in treating patients with severely calcified coronary artery lesions in Japan. Cardiovasc Interv Ther. 2017;Epub ahead of print, 5 September 2017; doi: 10.1007/s12928-017-0488-3.
Feller-Kopman D, Liu S, Geisler BP, DeCamp M, Pietzsch JB. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. J Thorac Oncol. 2017 May 11. pii: S1556-0864(17)30364-7. doi: 10.1016/j.jtho.2017.04.030. [Epub ahead of print]
Pietzsch JB, Garner AM, Marks WJ. Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States. Neuromodulation: Technology at the Neural Interface. doi:10.1111/ner.12474, August 2016.
Katsanos K, Geisler BP, Garner AM, Zayed H, Cleveland T, Pietzsch JB. Economic Analysis of Endovascular Drug-eluting Treatments for Femoropopliteal Artery Disease in the United Kingdom.BMJ Open 2016;6:e011245 doi:10.1136/bmjopen-2016-011245.
Feeley BT, Liu S, Garner AM, Zhang AL, Pietzsch JB. The Cost-Effectiveness of Meniscal Repair versus Partial Meniscectomy: A Model-Based Projection of Clinical Outcomes and Costs in the United States Healthcare System. The Knee; 23: 674-680, April 2016.
Noblett KL, Dmochowski RR, Vasavada SP, Garner AM, Liu S, Pietzsch JB. Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome. Neurourol Urodyn. 2016 Apr 6. doi: 10.1002/nau.23008.
Pietzsch JB, Liu S, Garner AM, Kezirian EJ, Strollo PJ. Long-Term Cost-Effectiveness of Upper Airway Stimulation for the Treatment of Obstructive Sleep Apnea: A Model-Based Projection Based on the STAR Trial. Sleep 2015;38:735-44.
Pietzsch JB, Garner AM, Herth FJ. “Cost-Effectiveness of Endobronchial Valve Therapy for Severe Emphysema: A Model-Based Projection Based on the VENT Study.” Respiration 2014;88:389–398 DOI: 10.1159/000368088.
Pietzsch JB, Geisler BP, Garner AM, Zeller T, Jaff MR. “Economic analysis of endovascular interventions for femoropopliteal arterial disease: A systematic review and budget impact model for the United States and Germany.” Catheterization and Cardiovascular Interventions (CCI) 84(4): 546-554. DOI: 10.1002/ccd.25536.
Pietzsch JB, Liu S, Kezirian EJ, Strollo P. “Long-term cost-effectiveness of Upper Airway Stimulation for the treatment of obstructive sleep apnea – A model-based projection based on the STAR Trial. SLEEP 2014, Minneapolis, MN, June 2, 2014.
Geisler BP, Egan BM, Cohen JT, Garner AM, Akehurst RL, Esler MD, Pietzsch JB. “Cost-Effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension.” JACC, Vol. 16, No. 14, 2012. October 2, 2012:1271–7.
Pietzsch JB; Zanchi MG, Linehan JH. “Medical Device Innovators and the 510(k) Regulatory Pathway: Implications of a Survey-Based Assessment of Industry Experience – Part 2: Medical Device Ecosystem and Policy”. J. Med. Devices 7(2), June 2013, doi:10.1115/1.4023131.
Pietzsch JB; Zanchi MG, Linehan JH. “Medical Device Innovators and the 510(k) Regulatory Pathway: Implications of a Survey-Based Assessment of Industry Experience”. Journal of Medical Devices, Vol.6, pp. 021015-021023, June 2012.
Pietzsch JB; Garner A; Cipriano LE; Linehan JH. “An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.” SLEEP 2011;34(6):695-709.
Pietzsch JB, Shluzas LA, Paté-Cornell ME, Yock PG, Linehan JH. “Stage-Gate Process for the Development of Medical Devices.” Journal of Medical Devices, 3:2 (2009).
Rao SK, Pietzsch JB. “Policy-Induced Constraints in the Design and Commercialization of Monitoring Devices.” Journal of Medical Devices, 3:2 (2009).
Arrow K, Auerbach A, et al. “Toward a 21st-Century Health Care System: Recommendations for Health Care Reform.” Ann Intern Med; 493-495 (2009).
DiDomenico PB, Pietzsch JB, Paté-Cornell ME. “Bayesian Assessment of Overtriage and Undertriage at a Level I Trauma Centre.” Philosophical Transactions of the Royal Society A – Theme Issue ‘Mathematical and statistical methods for diagnoses and therapies.’ April 2008.
Pietzsch JB, Paté-Cornell ME. “Early technology assessment of new medical devices“. International Journal of Technology Assessment in Health Care, 24:1 (2008), pp. 37–45.
Pietzsch JB, Aquino LM, Yock PG, Paté-Cornell ME, Linehan JH. “Review of U.S. Medical Device Regulation.” Journal of Medical Devices Vol. 1, December 2007, pp. 283-292.
Pietzsch J.B., “Early-stage technology assessment: methods and opportunities“, in: “Bringing HTA into practice – 2nd Annual HTAi Meeting, Rome, 20th-22nd June 2005”:Italian Journal of Public Health, Vol.2, No.2, Summer 2005, Supplement 1, pp.74-75.
Pietzsch J.B., Paté-Cornell M.E., Krummel T.M., “A Framework for Probabilistic Assessment of New Medical Technologies,” in: Spitzer C, Schmocker U, Dang VN. (eds.). “Probabilistic Safety Assessment and Management (PSAM7-ESREL’04): Proceedings of the 7th International Conference on Probabilistic Safety Assessment and Management, 14-18 June 2004, Berlin Germany.” Springer-Verlag , London UK (2004), pp.2224-2229.
Pietzsch J.B., Paté-Cornell M.E., Krummel T.M., “Methods for Early Assessment of New Medical Technologies: An Overview of Relevant Quantitative Modeling Tools,” Proceedings of the 19th Annual Meeting of the International Society of Technology Assessment in Health Care, Canmore, Canada, June 2003.
Haberland C.A., Benitz W.E., Sanders G.D., Pietzsch J.B., Yamada S., Nguyen L., Garber A.M., “Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction,“ Pediatrics, Vol. 110, No.3, September 2002, pp.471-80.
Pietzsch J.B., Krummel T.M., Paté-Cornell M.E., “Early Technology Assessment of New Medical Devices and Procedures: A Systems Analysis Approach using Probabilistic Modeling,” Proceedings of the 18th Annual Meeting of the International Society of Technology Assessment in Health Care, Berlin, Germany, June 2002.